• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S100P 通过 PKA/c-Jun 介导的肿瘤相关巨噬细胞募集和极化促进 LUAD 进展。

S100P facilitates LUAD progression via PKA/c-Jun-mediated tumor-associated macrophage recruitment and polarization.

机构信息

School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China; Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China.

School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China; Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China.

出版信息

Cell Signal. 2024 Aug;120:111179. doi: 10.1016/j.cellsig.2024.111179. Epub 2024 Apr 18.

DOI:10.1016/j.cellsig.2024.111179
PMID:38640980
Abstract

S100P, a member of the S100 calcium-binding protein family, is closely associated with abnormal proliferation, invasion, and metastasis of various cancers. However, its role in the lung adenocarcinoma (LUAD) tumor microenvironment (TME) remains unclear. In this study, we observed specific expression of S100P on tumor cells in LUAD patients through tissue immunofluorescence analysis. Furthermore, this expression was strongly correlated with the recruitment and polarization of tumor-associated macrophages (TAMs). Bioinformatics analysis revealed that high S100P expression is associated with poorer overall survival in LUAD patients. Subsequently, a subcutaneous mouse model demonstrated that S100P promotes recruitment and polarization of TAMs towards the M2 type. Finally, in vitro studies on LUAD cells revealed that S100P enhances the secretion of chemokines and polarizing factors by activating the PKA/c-Jun pathway, which is implicated in TAM recruitment and polarization towards the M2 phenotype. Moreover, inhibition of c-Jun expression impedes the ability of TAMs to infiltrate and polarize towards the M2 phenotype. In conclusion, our study demonstrates that S100P facilitates LUAD cells growth by recruiting M2 TAMs through PKA/c-Jun signaling, resulting in the production of various cytokines. Considering these findings, S100P holds promise as an important diagnostic marker and potential therapeutic target for LUAD.

摘要

S100P 是 S100 钙结合蛋白家族的一员,与各种癌症的异常增殖、侵袭和转移密切相关。然而,其在肺腺癌(LUAD)肿瘤微环境(TME)中的作用尚不清楚。在本研究中,我们通过组织免疫荧光分析观察到 LUAD 患者肿瘤细胞中 S100P 的特异性表达。此外,这种表达与肿瘤相关巨噬细胞(TAMs)的募集和极化强烈相关。生物信息学分析显示,S100P 高表达与 LUAD 患者总体生存率降低相关。随后,皮下小鼠模型表明 S100P 通过激活 PKA/c-Jun 通路促进 TAMs 向 M2 型募集和极化。最后,对 LUAD 细胞的体外研究表明,S100P 通过激活 PKA/c-Jun 通路增强趋化因子和极化因子的分泌,从而招募和极化 TAMs 向 M2 表型。此外,抑制 c-Jun 的表达会阻碍 TAMs 浸润和向 M2 表型极化的能力。总之,本研究表明,S100P 通过 PKA/c-Jun 信号通路招募 M2 TAMs 促进 LUAD 细胞生长,从而产生各种细胞因子。鉴于这些发现,S100P 有望成为 LUAD 的重要诊断标志物和潜在治疗靶点。

相似文献

1
S100P facilitates LUAD progression via PKA/c-Jun-mediated tumor-associated macrophage recruitment and polarization.S100P 通过 PKA/c-Jun 介导的肿瘤相关巨噬细胞募集和极化促进 LUAD 进展。
Cell Signal. 2024 Aug;120:111179. doi: 10.1016/j.cellsig.2024.111179. Epub 2024 Apr 18.
2
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
3
Mechanistic study of CTHRC1 in promoting Wilms' tumor progression by regulating M2-type tumor-associated macrophages polarization.CTHRC1通过调节M2型肿瘤相关巨噬细胞极化促进肾母细胞瘤进展的机制研究
J Transl Med. 2025 Jul 8;23(1):752. doi: 10.1186/s12967-025-06752-4.
4
Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation.揭示GPCR信号在肺腺癌代谢重编程和免疫微环境中的作用:一项具有实验验证的多组学研究
Front Immunol. 2025 Jun 6;16:1606125. doi: 10.3389/fimmu.2025.1606125. eCollection 2025.
5
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization.AXL通过调节免疫抑制性巨噬细胞极化促进炎性乳腺癌进展。
Breast Cancer Res. 2025 May 6;27(1):70. doi: 10.1186/s13058-025-02015-8.
6
ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2/STAT3 signaling pathway.β2肾上腺素能受体(ADRB2)受TRIM22调控,并通过JAK2/STAT3信号通路促进肺腺癌进展。
Sci Rep. 2025 Jul 1;15(1):22083. doi: 10.1038/s41598-025-06017-6.
7
Tumor-Associated Macrophage-Derived TGF-β1 Activates GLI2 via the Smad2/3 Signaling Pathway to Affect Cisplatin Resistance in Lung Adenocarcinoma.肿瘤相关巨噬细胞衍生的 TGF-β1 通过 Smad2/3 信号通路激活 GLI2 影响肺腺癌顺铂耐药。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241274337. doi: 10.1177/15330338241274337.
8
SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.SMC2 敲低通过上调 BTG2 表达抑制肺腺癌的恶性进展。
Cell Signal. 2024 Aug;120:111216. doi: 10.1016/j.cellsig.2024.111216. Epub 2024 May 8.
9
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.NR_109/FUBP1/c-Myc 轴调节 TAM 极化并重塑肿瘤微环境以促进癌症发展。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006230.
10
RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma.RBM15介导的XPR1的m6A修饰促进肺腺癌的恶性进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 10. doi: 10.1007/s00210-025-03849-x.

引用本文的文献

1
Multiple roles of S100P in pan carcinoma: Biological functions and mechanisms (Review).S100P在泛癌中的多重作用:生物学功能与机制(综述)
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8895. Epub 2025 Apr 11.
2
S100 Protein Family in Lung Cancer: an Updated Narrative Review.肺癌中的S100蛋白家族:最新叙述性综述
Cancer Manag Res. 2025 Mar 27;17:713-722. doi: 10.2147/CMAR.S508047. eCollection 2025.
3
Integrative analysis of genetic variability and functional traits in lung adenocarcinoma epithelial cells via single-cell RNA sequencing, GWAS, bayesian deconvolution, and machine learning.
通过单细胞RNA测序、全基因组关联研究(GWAS)、贝叶斯反卷积和机器学习对肺腺癌上皮细胞的遗传变异性和功能特征进行综合分析。
Genes Genomics. 2025 Apr;47(4):435-468. doi: 10.1007/s13258-025-01621-2. Epub 2025 Feb 24.
4
Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD.整合单细胞和批量RNA测序以鉴定独特的肿瘤干细胞并构建用于评估肺腺癌预后和免疫治疗的新型预后标志物。
J Transl Med. 2025 Feb 22;23(1):222. doi: 10.1186/s12967-025-06243-6.